ReviewExpert opinion on investigational drugs2017

BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations.

Mark C Markowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.